Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing

Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing — Live Feedhttps://www.live-feeds.com/feed/nature-retracts-provocative-pd-1-study-that-tied-lung-cancer-survival-to-treatment-timingContinuously updated, source-cited coverage. Nature Medicine Retracts Lung Cancer Immunotherapy Timing Studyhttps://www.live-feeds.com/feed/nature-retracts-provocative-pd-1-study-that-tied-lung-cancer-survival-to-treatment-timinghttps://www.live-feeds.com/feed/nature-retracts-provocative-pd-1-study-that-tied-lung-cancer-survival-to-treatment-timing#u18444Tue, 30 Jun 2026 06:41:12 +0000Nature Medicine retracted the Phase III LungTIME-C01 trial on June 24. The study previously claimed that administering anti-PD-1 agents before 3:00 PM improved survival for non-small cell lung cancer patients. Editors cited a loss of confidence in the integrity of the results.What's confirmed:Nature Medicine retracted the LungTIME-C01 Phase III trial on June 24.The study involved 210 patients with treatment naive stage IIIC-IV non-small cell lung cancer.The trial tested whether administering anti-PD-1 agents before or after 15:00 h affected outcomes.The retracted results claimed a median progr